The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index; 3 of the 6 sources its claims cite were checked for support.
Diabetes gestacional y riesgo de apnea obstructiva del sueño en el tercer trimestre
Open accessAbstract
Introduction: Physiological changes during pregnancy predispose women tocomplications such as gestational diabetes (GD) and obstructive sleep apnea (OSA).Recent studies suggest a possible relationship between the two conditions in the third trimester; however, this relationship has not yet been sufficiently explored in local contexts. Objective: To evaluate the association between gestational diabetes (GD) and the risk of obstructive sleep apnea (OSA) in third-trimester pregnant women. Methods: An observational, cross-sectional study included 152 pregnant women with ≥28 weeks' gestational age. OSA risk was assessed using the Epworth,STOP-BANG, and Mallampati scales, while the presence of GD was determined using the IADPSG criteria. Crude prevalence ratios (cPR) and adjusted prevalence ratios (aPR) with 95% confidence intervals were calculated. Results: A significantassociation was observed between the risk of OSA and gestational diabetes (cPR = 1.465) as well as with hyperglycemia (cPR = 2.03). After the adjusted analysis, only hyperglycemia showed a significant association (aPR = 1.985). Conclusion: The risk of OSA was significantly associated with hyperglycemia in pregnancy, suggesting apossible relationship with alterations in glycemic metabolism.
Overview
CoChat Summary
## TL;DR
This observational study of 152 third-trimester pregnant women in Piura, Peru found that high risk of obstructive sleep apnea (OSA) was associated with gestational diabetes in crude analysis, but after adjustment only gestational hyperglycemia remained significant. The authors conclude that OSA risk may be a marker of altered glucose metabolism during pregnancy.
## Key findings
- Among 152 pregnant women, 42.1% (n=64) were at high risk of OSA, 36.2% (n=55) at moderate risk, and 21.7% (n=33) at low risk.
- Gestational diabetes was present in 25.0% (n=38), and gestational hyperglycemia in 46.7% (n=71).
- In crude Poisson regression, high OSA risk was associated with gestational hyperglycemia (cPR = 2.034; 95% CI: 1.365–3.031; p = 0.001), gestational diabetes (cPR = 1.465; 95% CI: 1.011–2.123; p = 0.044), obesity (cPR = 1.518; 95% CI: 1.051–2.192; p = 0.026), and increased neck circumference (cPR = 1.738; 95% CI: 1.223–2.471; p = 0.002).
- In adjusted analysis, only gestational hyperglycemia remained significant (aPR = 1.985; 95% CI: 1.269–3.105; p = 0.003); gestational diabetes was no longer significant (aPR = 0.818; p = 0.331).
## Methods
- Observational, retrospective, analytical study of pregnant women in the third trimester.
- Sample: 152 pregnant women (38 with gestational diabetes and 114 without) treated at the Los Algarrobos Health Center and Castilla Health Center in Piura during 2024–2025.
- Gestational diabetes was identified using fasting glucose and IADPSG criteria; OSA risk was screened with the Epworth Sleepiness Scale, STOP-BANG, and Mallampati classification; associations were tested with chi-square and Poisson regression with robust variance to estimate crude and adjusted prevalence ratios.
## Limitations
- The paper explicitly states that the retrospective design and use of medical records may have introduced information bias or limited availability of relevant variables.
- The paper explicitly states that clinical screening tools do not replace polysomnography, the gold standard for OSA diagnosis.
- Evident from the text: OSA was assessed by screening risk tools rather than diagnostic sleep testing, so the outcome is risk of OSA, not confirmed OSA.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
3 Valid · 1 Not valid · 2 Not checked · 25 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Recent studies have proposed a potential association between GD and the risk of OSA during the third trimester”
What the sources say
- Partly supportedcites [1] 1. Tong X, Yang L, Jiang C, Weng Z, Zu A, Hou Y, etal. A Review of the Associations Between Obstructive Sleep Apnea and Gestational Diabetes Mellitus and Possible Mechanisms of Disease. Reprod Sci 2022;30(1):81-92. DOI: 10.1007/s43032022-00904-3 sourceExperimental — accuracy not yet measured
The Results sections on association and prevalence report an association between GDM and OSA and describe their co-occurrence in the third trimester. They do not establish that women with GDM have an increased risk of OSA specifically during the third trimester; the third-trimester figure instead describes GDM prevalence among women with severe OSA. Page numbers were not available in our copy. (LLM, conf=0.82)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The study by Izci Balserak et al. (24) reinforces the evidence that the risk of OSA is significantly related to metabolic alterations during pregnancy.”
What the sources say
- Supportedcites [24] 24. Izci Balserak B, Pien GW, Prasad B, Mastrogiannis D, Park C, Quinn LT, etal. Obstructive Sleep Apnea Is Associated with Newly Diagnosed Gestational Diabetes Mellitus. Ann Am Thorac Soc 2020;17(6):754-61. DOI: 10.1513/AnnalsATS.201906-473OC source
The Abstract (Results/Conclusions) of our copy reports that OSA (AHI > 5 events/h) was present in 22% of subjects with GDM versus 9% of controls and that women with OSA had higher GDM risk (OR 4.71; 95% CI 1.05-21.04), with significant dose-response associations for overall AHI, AHI in REM, ODI4 and symptom score. The concluding paragraph states explicitly that 'the present results also confirm previous studies that found an association between SDB and GDM,' which is exactly the 'reinforces the evidence' proposition attributed here. The only narrowing is that the metabolic alteration this study actually measured was glucose dysregulation/GDM, not metabolic changes generally, but the claim's substance (a significant OSA-metabolic relation in pregnancy) is stated by the source. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“| Increased neck circum- ference | 1.382 | 0.963 - 1.983 | 0.079 |”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“46.7% (N=71) of pregnant women had gestational hyperglycemia”
plainn = 71- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“increased neck circumference (PR = 1.74; p = 0.002)”
- Also stated in: § Results · plain
“| Neck circumference Increased | 1.738 | 1.223 - 2.471 | 0.002 |”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
9 more claims
Create a free account to see all 31 claims and every source verdict.
- Probably not a substantial claim. 9
- It may state two separate claims as one. 6
- The quote only partly states this claim. 3
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Research works printed but not linked: 1
- [12]12. Torres WP, Juez AE, González JL, Barzola CV, Vélez DG, Torres DA, etal. Gestational diabetes: Pathophysiology, diagnosis, treatment and new perspectives. Arch Venez Farmacol Ter 2018;37:218-26.
Metadata
- Authors
- Panta-Chumacero, K. D., & Serna Alarcón, V.
- Venue
- Revista Peruana de Ginecología y Obstetricia
- Published
- 2025-11-28
- Volume
- 71
- Issue
- 2
- ISSN
- 2304-5124 (ISSN-L)
- 2304-5132
- OpenAlex
- W4416804070
- Cited by
- 0
- References
- 0
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Revista Peruana de Ginecología y Obstetricia (publishedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- gestational diabetes mellitus, obstructive sleep apnea, third trimester, hyperglycemia, OSA risk factors, STOP-BANG questionnaire, Mallampati score, Epworth scale, glucose metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diabetes gestacional y riesgo de apnea obstructiva del sueño en el tercer trimestre. https://app.cochat.ai/papers/10.31403/rpgo.v71i2779
- The paper
- Panta-Chumacero, K. D., & Serna Alarcón, V. (2025). Diabetes gestacional y riesgo de apnea obstructiva del sueño en el tercer trimestre. Revista Peruana de Ginecología y Obstetricia. https://doi.org/10.31403/rpgo.v71i2779
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
